Showing 1 - 10 of 107
This paper looks at the outsourcing of research and development (Ramp;D) activities. We consider cost reducing Ramp;D and allow manufacturing firms to decide whether to outsource the project to research subcontractors or carry out the research in-house. We use a principal-agent framework and...
Persistent link: https://www.econbiz.de/10012711606
Persistent link: https://www.econbiz.de/10007645382
Persistent link: https://www.econbiz.de/10007658572
Persistent link: https://www.econbiz.de/10005531267
This paper develops a growth model aimed at understanding the potential effects of globalization of production on rate of innovation, distribution of skilled labor income between the North and South, and welfare of skilled workers in both regions. We adopt a dynamic general equilibrium...
Persistent link: https://www.econbiz.de/10005410541
We derive a simple equation to calculate the global welfare impact of the simultaneous reduction of trade costs between multiple country-pairs. Interestingly, we find that we obtain the same equation for a broad class of trade models. Moreover, balanced trade is mostly not required for the...
Persistent link: https://www.econbiz.de/10011081739
We construct a tractable general equilibrium model of cumulative innovation and growth, in which new ideas strictly improve upon frontier technologies, and productivity improvements are drawn in a stochastic manner. The presence of positive knowledge spillovers implies that the decentralized...
Persistent link: https://www.econbiz.de/10011081773
This paper develops a growth model aimed at understanding the effects of globalization of production on rate of innovation, distribution of labor income between the North and South and welfare of workers in both regions. We adopt a dynamic general equilibrium product cycle model, assuming that...
Persistent link: https://www.econbiz.de/10004993778
Persistent link: https://www.econbiz.de/10005096297
Price controls create opportunities for international arbitrage. Many have argued that such arbitrage, if tolerated, will undermine intellectual property rights and dull the incentives for investment in research-intensive industries such as pharmaceuticals. We challenge this orthodox view and...
Persistent link: https://www.econbiz.de/10005666872